Although it “has stirred significant controversy in recent years,” the Congressional Research Service policy of restricting direct dissemination of its products to members of Congress is well-founded, argued CRS director Daniel P. Mulhollan in a lengthy internal memorandum (pdf) last month.
“The reasons for limiting public distribution of our work can be summarized as follows,” he wrote.
“First, there is a danger that placing CRS in an intermediate position [between Congress and the public] would threaten the dialog on policy issues between Members and their constituents.”
“Second, the current judicial … perception of CRS as ‘adjunct staff’ of the Congress might be altered if CRS were seen as speaking directly to the public, putting at risk Speech or Debate Clause constitutional protections afforded the confidential work performed by this agency.”
“And third, if CRS products were routinely disseminated broadly to the public, over time these products might come to be written with a large public audience in mind and would no longer be focused solely on congressional needs.”
A copy of Director Mulhollan’s seven page memorandum on “Access to CRS Reports,” dated April 18, 2007, was obtained by Secrecy News and is available here.
The arguments detailed by Mr. Mulhollan seem singularly unpersuasive to an outsider. CRS is not being called upon to mediate between Congress and the public or to engage in a public dialog on policy issues. Rather, proponents of broader dissemination are simply asking for the same public access that commercial vendors of CRS reports already enjoy.
In anticipation of future known and unknown health security threats, including new pandemics, biothreats, and climate-related health emergencies, our answers need to be much faster, cheaper, and less disruptive to other operations.
To unlock the full potential of artificial intelligence within the Department of Health and Human Services, an AI Corps should be established, embedding specialized AI experts within each of the department’s 10 agencies.
Investing in interventions behind the walls is not just a matter of improving conditions for incarcerated individuals—it is a public safety and economic imperative. By reducing recidivism through education and family contact, we can improve reentry outcomes and save billions in taxpayer dollars.
The U.S. government should establish a public-private National Exposome Project (NEP) to generate benchmark human exposure levels for the ~80,000 chemicals to which Americans are regularly exposed.